Protalix BioTherapeutics, Inc. Annual Return On Equity in % from 2011 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2011 to 2023.
  • Protalix BioTherapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -30.9 %, a 149% decline year-over-year.
  • Protalix BioTherapeutics, Inc. annual Return On Equity for 2023 was 29.7 %, a 80.3% decline from 2022.
  • Protalix BioTherapeutics, Inc. annual Return On Equity for 2022 was 151 %.
  • Protalix BioTherapeutics, Inc. annual Return On Equity for 2021 was -881 %, a 4355% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 29.7 -121 -80.3% Jan 1, 2023 Dec 31, 2023
2022 151 +1.03K Jan 1, 2022 Dec 31, 2022
2021 -881 -902 -4355% Jan 1, 2021 Dec 31, 2021
2020 20.7 -6.52 -23.9% Jan 1, 2020 Dec 31, 2020
2019 27.2 -31.9 -53.9% Jan 1, 2019 Dec 31, 2019
2018 59.1 -172 -74.4% Jan 1, 2018 Dec 31, 2018
2017 231 -156 -40.3% Jan 1, 2017 Dec 31, 2017
2016 387 +513 Jan 1, 2016 Dec 31, 2016
2015 -126 -194 -286% Jan 1, 2015 Dec 31, 2015
2014 67.8 -112 -62.2% Jan 1, 2014 Dec 31, 2014
2013 180 +1.83K Jan 1, 2013 Dec 31, 2013
2012 -1.65K -1.96K -635% Jan 1, 2012 Dec 31, 2012
2011 308 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.